Also published in 4-traders : one website, all markets:
A2A SpA : First meeting of the Management Board
x hide permanently

SteadyMed Shareholders Approve Proposed Acquisition by United Therapeutics

4-traders : one website, all markets

(GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq: STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with unmet parenteral delivery needs, today announced that SteadyMed shareholders voted to approve the previously announced acquisition of the company by United Therapeutics Corporation (NASDAQ: UTHR) at an extraordinary general meeting of shareholders held on July 30, 2018...

Mentions: acquisition United Therapeutics